Literature DB >> 1316669

Molecular mechanisms of visna virus Tat: identification of the targets for transcriptional activation and evidence for a post-transcriptional effect.

S L Gdovin1, J E Clements.   

Abstract

Visna virus is a pathogenic lentivirus of sheep that is distantly related to the primate lentiviruses, including the human immunodeficiency virus type 1 (HIV-1). Replication of HIV-1 in cell culture requires the expression of a virus-encoded protein, Tat, which is a potent trans-activator of viral gene expression. Visna virus encodes an analogous Tat protein that greatly increases gene expression directed by the visna viral LTR. This report uses a stable vero cell line that constitutively expresses visna virus Tat to investigate the molecular mechanism of action of Tat on viral gene expression. Transient expression assays, using the visna virus LTR to drive transcription of the bacterial gene for chloramphenicol acetyltransferase (CAT), demonstrate that Tat trans-activates gene expression by increasing steady-state mRNA levels. The increase in steady-state mRNA levels is sufficient to account for the increase in protein observed and is due, in part, to an increase in the rate of transcription initiation. Tat mediates the accumulation of mRNA through AP-4 and AP-1 binding sites located in the U3 region of the LTR. Deletion of the upstream AP-1 and AP-4 binding sites results in a residual low level of trans-activation by Tat. Further experiments, using LTRs with R-U5 sequences deleted to +10, demonstrate AP-1 and AP-4 mediated responses to TAT at the RNA level, but no increase was observed in CAT protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316669     DOI: 10.1016/0042-6822(92)90497-d

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  Caprine arthritis encephalitis virus dysregulates the expression of cytokines in macrophages.

Authors:  F Lechner; J Machado; G Bertoni; H F Seow; D A Dobbelaere; E Peterhans
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  The leucine domain of the visna virus Tat protein mediates targeting to an AP-1 site in the viral long terminal repeat.

Authors:  L M Carruth; B A Morse; J E Clements
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

3.  Maedi-visna virus and caprine arthritis encephalitis virus genomes encode a Vpr-like but no Tat protein.

Authors:  Stéphanie Villet; Baya Amel Bouzar; Thierry Morin; Gérard Verdier; Catherine Legras; Yahia Chebloune
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

4.  Duplicated sequence motif in the long terminal repeat of maedi-visna virus extends cell tropism and is associated with neurovirulence.

Authors:  Thórdur Oskarsson; Hulda S Hreggvidsdóttir; Gudrún Agnarsdóttir; Sigrídur Matthíasdóttir; Margrét H Ogmundsdóttir; Stefán R Jónsson; Gudmundur Georgsson; Sigurdur Ingvarsson; Olafur S Andrésson; Valgerdur Andrésdóttir
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

5.  Targeting of the visna virus tat protein to AP-1 sites: interactions with the bZIP domains of fos and jun in vitro and in vivo.

Authors:  B A Morse; L M Carruth; J E Clements
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

6.  Demonstration that orf2 encodes the feline immunodeficiency virus transactivating (Tat) protein and characterization of a unique gene product with partial rev activity.

Authors:  A de Parseval; J H Elder
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

7.  Visna virus Tat protein: a potent transcription factor with both activator and suppressor domains.

Authors:  L M Carruth; J M Hardwick; B A Morse; J E Clements
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

8.  The nucleolus is the site of Borna disease virus RNA transcription and replication.

Authors:  J M Pyper; J E Clements; M C Zink
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

Review 9.  The genome of feline immunodeficiency virus.

Authors:  T Miyazawa; K Tomonaga; Y Kawaguchi; T Mikami
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

10.  Multiple positive and negative cis-acting elements that mediate transactivation by bel1 in the long terminal repeat of human foamy virus.

Authors:  K J Lee; A H Lee; Y C Sung
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.